Product Images Labetalol Hydrochloride
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 4 images provide visual information about the product associated with Labetalol Hydrochloride NDC 55154-0181 by Cardinal Health 107, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
300mg bag label - D3CA153C 25B2 4506 91BD BF9D6A4C01FE 00
This is a description of Labetalol Hydrochloride Tablets, USP, containing 300 mg of labetalol hydrochloride per tablet. The usual dosage instructions are provided in the product insert including prescribing information, precautions and warnings. The tablets should be stored at a temperature range of 20°C to 25°C (68°F to 77°F). The package is not child-resistant and intended for institutional use only. The drug product is from NDC # 70377-062, Blocon Pharma Inc., and it is packaged and distributed by MAJOR® PHARMACEUTICALS in Indianapolis, USA, with Cardinal Health being the distributor in Dublin.*
200mg bag label - D3CA153C 25B2 4506 91BD BF9D6A4C01FE 01
This text is a label for Labetalol Hydrochloride tablets, USP, with a strength of 200 mg per tablet. The label provides information on dosage, storage instructions, manufacturer details, and a warning about child resistance. It is intended for institutional use only and should be kept out of reach of children. The product is distributed by Major Pharmaceuticals via Cardinal Health.*
100mg bag label - D3CA153C 25B2 4506 91BD BF9D6A4C01FE 02
This is a description of labetalol hydrochloride tablets, USP, each containing 100 mg of labetalol. The usual dosage information can be found in the product insert, along with prescribing details, precautions, and warnings. Storage instructions are to keep the tablets between 20°C to 25°C (68°F to 77°F). This medication should be dispensed in a tight, light-resistant container with a child-resistant closure. Note that the package is not child-resistant and is intended for institutional use only. The drug product in the package is from NDC # 70377-060 by Biocon Pharma Inc. The tablets are distributed by Major Pharmaceuticals in Indianapolis, USA, through Cardinal Health.*
Chem Structure - chemstructure
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
